Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3896966 | Seminars in Nephrology | 2013 | 9 Pages |
Abstract
African Americans have lower 25-hydroxyvitamin D (25(OH)D) levels compared with whites. African Americans also have a higher risk of developing albuminuria and end-stage renal disease but a lower risk of death once they commence hemodialysis compared with whites. Vitamin D levels have been associated with multiple outcomes including albuminuria, progression to end-stage renal disease, and all-cause and cardiovascular mortality. In this review, we examine the evidence linking 25(OH)D to outcomes and the possibility that differential 25(OH)D may explain certain racial differences in outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Utibe MD, Narender MD, Michal L. MD, MHS,